Brinkley Ruth Williams

Insider Reports History

Location
San Diego, CA
Signature
/s/ Tami Chen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brinkley Ruth Williams:

Company Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 5,389 $1,234,566 $229.09 30 Jan 2026 Direct
Travere Therapeutics, Inc. Director Common Stock 25,750 $471,997 $18.33 15 May 2025 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19,500 15 May 2025 Direct

Insider Reports Filed by Brinkley Ruth Williams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTRA Natera, Inc. 30 Jan 2026 1 $0 4 Director 03 Feb 2026, 20:35
NTRA Natera, Inc. 31 Oct 2025 1 $0 4 Director 04 Nov 2025, 21:05
NTRA Natera, Inc. 25 Jul 2025 1 $0 4 Director 29 Jul 2025, 21:05
NTRA Natera, Inc. 27 Jun 2025 1 $0 4 Director 01 Jul 2025, 21:15
TVTX Travere Therapeutics, Inc. 15 May 2025 2 $0 4 Director 16 May 2025, 19:00
NTRA Natera, Inc. 28 Jun 2024 1 $0 4 Director 02 Jul 2024, 21:05
TVTX Travere Therapeutics, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 16:06
NTRA Natera, Inc. 27 Oct 2023 1 +$12,890 4 Director 31 Oct 2023, 21:35
NTRA Natera, Inc. 28 Jul 2023 1 +$12,703 4 Director 01 Aug 2023, 21:05
TVTX Travere Therapeutics, Inc. 17 May 2023 2 $0 4 Director 19 May 2023, 16:05
NTRA Natera, Inc. 14 Apr 2023 1 +$3,946 4 Director 18 Apr 2023, 20:10
NTRA Natera, Inc. 24 Mar 2023 1 $0 4 Director 28 Mar 2023, 21:45
NTRA Natera, Inc. 02 Mar 2023 0 $0 3 Director 10 Mar 2023, 15:47
TVTX Travere Therapeutics, Inc. 11 May 2022 2 $0 4 Director 12 May 2022, 20:42
TVTX Travere Therapeutics, Inc. 14 Sep 2021 2 $0 4 Director 16 Sep 2021, 18:16
TVTX Travere Therapeutics, Inc. 14 Sep 2021 0 $0 3 Director 16 Sep 2021, 18:14